Tech Company Financing Transactions

Reprieve Cardiovascular Funding Round

On 2/20/2024, Reprieve Cardiovascular raised $42 million in Series A funding from Lightstone Ventures, Sante Ventures and Arboretum Ventures.

Transaction Overview

Announced On
2/20/2024
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series A
Proceeds Purpose
The funding will advance the Company's clinical and development programs, including the ongoing FASTR trial and its upcoming pivotal trial.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
459 Fortune Blvd.
Milford, MA 01757
USA
Email Address
Overview
Reprieve Cardiovascular is a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF). The company's Reprieve technology is being investigated as an innovative fluid management therapy.
Profile
Reprieve Cardiovascular LinkedIn Company Profile
Social Media
Reprieve Cardiovascular Company Twitter Account
Company News
Reprieve Cardiovascular News
Facebook
Reprieve Cardiovascular on Facebook
YouTube
Reprieve Cardiovascular on YouTube

Management Team

Title
Name
Email & Social
Chairman
Alexander Martin
  Alexander Martin LinkedIn Profile  Alexander Martin Twitter Account  Alexander Martin News  Alexander Martin on Facebook
Chief Executive Officer
James Dillon
  James Dillon LinkedIn Profile  James Dillon Twitter Account  James Dillon News  James Dillon on Facebook
Chief Medical Officer
Howard Levin
  Howard Levin LinkedIn Profile  Howard Levin Twitter Account  Howard Levin News  Howard Levin on Facebook
Chief Technical Officer
Andrew Halpert
  Andrew Halpert LinkedIn Profile  Andrew Halpert Twitter Account  Andrew Halpert News  Andrew Halpert on Facebook
VP - Bus. Development
Gregory Mann
  Gregory Mann LinkedIn Profile  Gregory Mann Twitter Account  Gregory Mann News  Gregory Mann on Facebook
VP - Operations
Kenneth Luppi
  Kenneth Luppi LinkedIn Profile  Kenneth Luppi Twitter Account  Kenneth Luppi News  Kenneth Luppi on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/20/2024: Bioptimus venture capital transaction
Next: 2/20/2024: Trace Genomics venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary